SPSIP vs ESP Block for Analgesia After Rib Fracture Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAntalya City Hospital

About this trial

This randomized clinical trial aims to evaluate and compare the analgesic efficacy of the Serratus Posterior Superior Intercostal Plane (SPSIP) block and the Erector Spinae Plane (ESP) block in patients undergoing surgical stabilization of rib fractures. The primary outcome is the Visual Analog Scale (VAS) score within the first 24 hours after surgery. Secondary outcomes include total opioid consumption, requirement for rescue analgesia, block performance time, block-related and systemic side effects (hematoma, pneumothorax, local anesthetic systemic toxicity, vascular puncture, and infection), patient satisfaction assessed using a Likert scale, and quality of recovery assessed using the QoR-15 questionnaire.

Eligibility criteria

Qualifiers

Patients aged 18-65 years

ASA physical status I-III

Scheduled for elective video-assisted thoracoscopic surgery

Body mass index (BMI) between 18 and 35 kg/m²

Disqualifiers

Refusal to participate

Allergy to local anesthetics

Infection at the injection site

Coagulopathy or ongoing anticoagulant therapy

Trial design

Treatments tested in this trial

  • Erector Spinae Plane Block (ESP)
  • Serratus Posterior Superior Intercostal Plane (SPSIP)

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators